Pharmaceutical companies that specialize in diabetes are targeting the Persian Gulf for investment by forming local partnerships and eying the establishment of manufacturing facilities to cater to the millions of people forecast to develop the disease within the next two decades The region is one of the next frontiers for those drug companies that are looking for growth and have already invested in developing their businesses in the emerging markets of China India Russia and Brazil consultants say